1. Borges L, Miller RE, Jones J, Ariail K, Whitmore J, Fanslow W, Lynch DH. (1999) Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo. J Immunol 163(3):1289–1297
2. Chakravarty PK, Alfieri A, Thomas EK, Beri V, Tanaka KE, Vikram B, Guha C. (1999) Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res 59(24):6028–6032
3. Darcy PK, Haynes NM, Snook MB, Trapani JA, Cerruti L, Jane SM, Smyth MJ. (2000) Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL. J Immunol 164(7):3705–3712
4. Djazayeri K, Szilvassy Z, Peitl B, Nemeth J, Nagy L, Kiss A, Szabo B, Benko I (2005) Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment. Eur J Pharmacol 522(1–3):122–129
5. Drakes ML, Lu L, Subbotin VM, Thomson AW (1997) In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J Immunol 159(9):4268–4278